Table 1 The 21 patients in Fig. 3 and the time interval for monitoring M-protein during chemotherapy.

From: Dynamic monitoring of M-protein quantification by immunotyping using capillary zone electrophoresis during the chemotherapy of patients with multiple myeloma

Patient number

Sex

Age (years)

Newly diagnosed at the first monitoring

Interval between the monitoring point and the previous one (days)

1

2

3

4

5

6

7

1

F

66

Yes

0

37

33

35

29

34

30

The 8th to 9th monitoring

45

29

     

2

F

50

No

0

44

27

35

38

  

3

M

55

No

0

140

160

173

79

96

 

4

F

56

No

0

37

40

45

46

36

28

The 8th to 14th monitoring

40

35

35

99

36

43

46

5

F

55

Yes

0

42

229

107

152

  

6

M

79

No

0

32

65

29

33

  

7

M

63

Yes

0

28

31

154

88

98

55

8

M

55

No

0

52

35

    

9

M

77

No

0

41

84

21

122

  

10

M

74

No

0

28

38

76

53

71

104

11

M

68

Yes

0

301

     

12

M

72

Yes

0

61

30

    

13

M

79

Yes

0

70

     

14

F

72

Yes

0

58

31

29

   

15

M

60

Yes

0

101

140

    

16

M

53

Yes

0

367

116

    

17

F

67

No

0

407

343

176

43

  

18

M

70

No

0

169

221

    

19

F

66

Yes

0

47

31

35

   

20

M

53

Yes

0

32

17

105

510

43

 

21

F

56

Yes

0

100

106

    
  1. Age was recorded when first monitored.